Uncategorized
UCB plots epilepsy expansion with $650M Neurona cell therapy acquisition
UCB plans to pay $650 million to Neurona Therapeutics in a bid to broaden its clinical-stage epilepsy portfolio.
The deal comes with as much as $500 million in milestone payments.
Neurona is developing a treatment …